{"schema_version":"secwatch.filing_event.v1","accession":"0000950157-24-000591","form_type":"8-K","ticker":"ILMN","cik":"0001110803","company_name":"ILLUMINA, INC.","filed_at":"2024-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.326503+00:00","generated_at":"2026-06-04T00:43:09.330997+00:00","sec_items":["5.02","7.01","2.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Illumina names Ankur Dhingra CFO; Joydeep Goswami departs; Q1/FY24 guidance reaffirmed","bullets":["Ankur Dhingra appointed CFO effective April 15, 2024; previously CFO of Summit Therapeutics (SMMT) and CareDx.","Joydeep Goswami leaves Illumina, stays as advisor through June 30; departure not due to disagreement.","Jakob Wedel named Chief Strategy and Corporate Development Officer, effective immediately.","Dhingra receives $650k base salary, $500k cash sign-on, $3.5M equity grant (70% PSUs, 30% RSUs), $15k monthly travel stipend.","Illumina reaffirms Q1 2024 and full-year 2024 financial guidance as announced on February 8, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950157-24-000591","json":"https://secwatch.observer/filing/0000950157-24-000591.json","markdown":"https://secwatch.observer/filing/0000950157-24-000591.md","text":"https://secwatch.observer/filing/0000950157-24-000591.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1110803/000095015724000591/0000950157-24-000591-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1110803/000095015724000591/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T00:43:09.330997+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b65f44af14ca66d678dbf12a5748286268d6a357","claim":"ILLUMINA, INC. updated its first quarter 2024 and full-year 2024 guidance (reaffirmed).","evidence_excerpt":"The company has reaffirmed its guidance for the first quarter 2024 and full-year 2024, as announced during its fourth quarter 2024 earnings call on February 8, 2024.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1110803/000095015724000591/0000950157-24-000591-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter 2024 and full-year 2024"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"2d648292e3","claim":"Ankur Dhingra was appointed as Chief Financial Officer at ILLUMINA, INC..","evidence_excerpt":"Ankur Dhingra has been appointed Chief Financial Officer of the Company, effective April 15, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1110803/000095015724000591/0000950157-24-000591-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"a51e7358eb","claim":"Joydeep Goswami departed as Chief Financial Officer at ILLUMINA, INC..","evidence_excerpt":"Joydeep Goswami has decided to leave Illumina. He will stay on in an advisory role through June 30 to support two new executive management team appointments.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1110803/000095015724000591/0000950157-24-000591-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will cease to serve"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}